Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.

One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD.Semi-structured and individual in-depth interview...

Full description

Bibliographic Details
Main Authors: Siew Ching Ho, Sabrina Anne Jacob, Balamurugan Tangiisuran
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5470687?pdf=render
_version_ 1818030018965536768
author Siew Ching Ho
Sabrina Anne Jacob
Balamurugan Tangiisuran
author_facet Siew Ching Ho
Sabrina Anne Jacob
Balamurugan Tangiisuran
author_sort Siew Ching Ho
collection DOAJ
description One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD.Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach.A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks.Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.
first_indexed 2024-12-10T05:28:55Z
format Article
id doaj.art-8cf08e756fe04b7090c08dfce239bc3c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T05:28:55Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8cf08e756fe04b7090c08dfce239bc3c2022-12-22T02:00:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017929010.1371/journal.pone.0179290Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.Siew Ching HoSabrina Anne JacobBalamurugan TangiisuranOne of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD.Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach.A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks.Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.http://europepmc.org/articles/PMC5470687?pdf=render
spellingShingle Siew Ching Ho
Sabrina Anne Jacob
Balamurugan Tangiisuran
Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
PLoS ONE
title Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
title_full Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
title_fullStr Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
title_full_unstemmed Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
title_short Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
title_sort barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder a qualitative study
url http://europepmc.org/articles/PMC5470687?pdf=render
work_keys_str_mv AT siewchingho barriersandfacilitatorsofadherencetoantidepressantsamongoutpatientswithmajordepressivedisorderaqualitativestudy
AT sabrinaannejacob barriersandfacilitatorsofadherencetoantidepressantsamongoutpatientswithmajordepressivedisorderaqualitativestudy
AT balamurugantangiisuran barriersandfacilitatorsofadherencetoantidepressantsamongoutpatientswithmajordepressivedisorderaqualitativestudy